Biofrontera (BFRI) EPS (Weighted Average and Diluted): 2021-2025
Historic EPS (Weighted Average and Diluted) for Biofrontera (BFRI) over the last 5 years, with Sep 2025 value amounting to -$0.62.
- Biofrontera's EPS (Weighted Average and Diluted) rose 36.73% to -$0.62 in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.49, marking a year-over-year decrease of 332.81%. This contributed to the annual value of -$3.22 for FY2024, which is 75.27% up from last year.
- Latest data reveals that Biofrontera reported EPS (Weighted Average and Diluted) of -$0.62 as of Q3 2025, which was down 8.77% from -$0.57 recorded in Q2 2025.
- Over the past 5 years, Biofrontera's EPS (Weighted Average and Diluted) peaked at $4.55 during Q4 2023, and registered a low of -$7.23 during Q2 2023.
- Moreover, its 3-year median value for EPS (Weighted Average and Diluted) was -$0.57 (2025), whereas its average is -$1.18.
- As far as peak fluctuations go, Biofrontera's EPS (Weighted Average and Diluted) spiked by 262.50% in 2023, and later plummeted by 1,040.00% in 2025.
- Over the past 5 years, Biofrontera's EPS (Weighted Average and Diluted) (Quarterly) stood at -$2 in 2021, then decreased by 13.00% to -$2.80 in 2022, then soared by 262.50% to $4.55 in 2023, then slumped by 96.26% to $0.17 in 2024, then soared by 36.73% to -$0.62 in 2025.
- Its EPS (Weighted Average and Diluted) was -$0.62 in Q3 2025, compared to -$0.57 in Q2 2025 and -$0.47 in Q1 2025.